US Stock MarketDetailed Quotes

ARDX Ardelyx

Watchlist
  • 5.3600
  • +0.1400+2.68%
Close Feb 28 16:00 ET
  • 5.3990
  • +0.0390+0.73%
Post 20:01 ET
1.28BMarket Cap-31.53P/E (TTM)

About Ardelyx Company

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Company Profile

SymbolARDX
Company NameArdelyx
Listing DateJun 19, 2014
Issue Price14.00
Founded2007
CEOMr. Michael G. Raab
MarketNASDAQ
Employees395
Fiscal Year Ends12-31
Address400 Fifth Avenue,Suite 210
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-510-745-1700
Websitehttp://www.ardelyx.com

Company Executives

  • Name
  • Position
  • Salary
  • Michael G. Raab
  • Director, President and Chief Executive Officer
  • 4.12M
  • Susan Rodriguez
  • Chief Commercial Officer
  • --
  • David P. Rosenbaum
  • Chief Development Officer
  • --
  • Dr. Laura Willia M.D.
  • Chief Medical Officer
  • 1.63M
  • Robert Blanks
  • Chief Regulatory Affairs and Quality Assurance Officer
  • --
  • Justin A. Renz
  • Chief Financial and Operations Officer
  • --
  • Elizabeth Grammer
  • Chief Legal and Administrative Officer
  • 1.63M
  • Joseph Reilly
  • Principal Accounting Officer
  • --
  • Mike Kelliher
  • Executive Vice President, Corporate Development and Strategy
  • --
  • David M. Mott
  • Chairman of the Board
  • 249.90K
  • Dr. Jan M. Lundberg, PhD
  • Independent Director
  • 199.90K
  • Onaiza Cadoret-Manier
  • Independent Director
  • 199.90K
  • Robert B. Bazemore, Jr
  • Independent Director
  • 202.40K
  • Muna Bhanji, Ph.
  • Independent Director
  • 202.40K
  • Richard J. Rodgers
  • Independent Director
  • 222.40K
  • William C. Bertrand, Esq.,Jr
  • Independent Director
  • 214.90K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Strategy
MSTR
+6.41%
MARA Holdings
MARA
+6.02%
NVIDIA
NVDA
+3.97%
Tesla
TSLA
+3.91%
Coinbase
COIN
+3.48%

Unlock the Full List